Irvine-based Ista Pharmaceuticals Inc. on Friday said its ecabet sodium dry eye treatment was effective in a mid-stage trial and announced plans for a new test. The news sent Ista’s shares up as much ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback